Browse > Article

Update in varicella vaccination  

Oh, Sung Hee (Department of Pediatrics, College of Medicine, Hanyang University)
Publication Information
Clinical and Experimental Pediatrics / v.49, no.3, 2006 , pp. 229-234 More about this Journal
Abstract
Varicella, which is mostly a benign disease, but also can cause considerable health burden in the community, can be prevented by immunization with live attenuated varicella vaccine. Higher uptake of varicella vaccine by universal immunization in North America has apparently been associated with decline in the number of reported cases of varicella, varicella-related hospitalizations, and the number of deaths caused by complications of varicella. On the contrary, there has been some reluctance in endorsing varicella vaccine for universal immunization in most of European countries. Concerns include unanticipated outbreaks of varicella among vaccine recipients, risk of varicella among unvaccinated adults, risk of herpes zoster among vaccinees as well as unvaccinees. Recently developed measles, mumps, rubella, and varicella combination vaccine and herpes zoster vaccine that may be licensed in the upcoming years may be the solution for varicella vaccine to be utilized in a greater scale. In Korea several varicella vaccine products have been utilized since late 1980. The adoption of varicella vaccine for universal immunization since 2005 along with the changing view in varicella prevention strategy mandates more studies for immunogenecity and efficacy of varicella vaccines as well as more surveillance to delineate the changes in epidemiology of varicella in Korea.
Keywords
Varicella; Vaccine; Herpes zoster; Outbreak;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Meyer PA, Seward JF, Jumaan AO, Wharton M. Varicella mortality : trends before vaccine licensure in the United States, 1970-1994. J Infect Dis 2000;182:383-90   DOI
2 Sheffer R, Segal D, Rahamani S, Datal H, Linhart Y, Stein M, et al. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel. Pediatr Infect Dis J 2005;24:434-7   DOI   ScienceOn
3 Galil K, Fair E, Mountcastle N, Britz P, Seward J, Younger age at vaccination may increase risk of varicella vaccine failure. J infect Dis 2002;186:102-5   DOI   ScienceOn
4 Lee BR, Feaver SL, Miller CA, Hedberg CW, Ehresmann KR. An elementary school outbreak of varicella attributed to vaccine failure : policy implications. J Infect Dis 2004;190: 477-83
5 Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicellavaccination in the United States. N Engl J Med 2005;352:450-8.   DOI   ScienceOn
6 Volpi A. Varicella immunization and herpes zoster. Herpes 2005;12:59
7 Brisson M, Edmunds WJ. Varicella vaccination in England and Wales : cost-utility analysis. Arch Dis Child 2003;88: 862-9   DOI
8 Reisinger KS, Brown ML, Xu J, Sullivan BJ, Marshall GS, Nauert B, et al. A combination measles, mumps, rubella, and varicella vaccine(ProQuad) given to 4-to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax. Pediatrics 2006;117:265-72   DOI   ScienceOn
9 Watson B, Seward J, Yang A, Witte P, Lutz J, Chan C, et al. Postexposure effectiveness of varicella vaccine. Pediatrics 2000;105:85-8   DOI   ScienceOn
10 Kang JH, Kim JH, Suh BK. The Immunogenicity and safety study of 47 passaged Oka strain live attenuated varicella vaccine in healthy children. Korean J Pediatr Infect Dis 1997;4:257-64   DOI
11 Takahashi M. Effectiveness of live varicella vaccine. Expert Opin Biol Ther 2004;4:199-216   DOI   ScienceOn
12 Weibel RE, Kuter BJ, Neff BJ, Rothenberger CA, Fitzgerald AJ, Connor KA, et al. Live Oka/Merck varicella vaccine in healthy children. Further clinical and laboratory assessment. JAMA 1985;254:2435-9   DOI
13 Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA 2005;294:797-802   DOI   ScienceOn
14 White CJ, Kuter BJ, Hilderbrand CS, Isganitis KL, Matthews H, Miller WJ, et al. Varicella vaccine(Varivax) in healthy children and adolescents : results from clinical trials, 1987-89. Pediatrics 1991;87:604-10
15 Li, Shu, Chan ISF, Matthews H, Heyse J, Chan CY. Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection. Pediatr Infect Dis J 2002;21:337-42   DOI   ScienceOn
16 Kim MR, Park JS, Kim DH, Lee HR, Park CY. A clinical and epidemiologic study on varicella in children. Korean J Pediatr Inf Dis 1998;5:88-95
17 Shinefield H, Black S, Digilio L, Reisinger K, Blatter M, Gress JO, et al. Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine inhealthy children. Pediatr Infect Dis J 2005;24:665-9   DOI   ScienceOn
18 Hall S, Maupin T, Seward J, Jumaan AO, Peterson C, Goldman G, et al. Second varicella infections : Are they more common than previously thought- Pediatrics 2002;19:1068-73
19 Seward J, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002;287:606-11   DOI
20 Brisson and Edmuds. The cost-effectiveness of varicella vaccination in Canada. Vaccine 2002;20:1113-25   DOI   ScienceOn
21 Morales-Castillo ME, Alvarez-Muñoz MT, Solórzano-Santos F, González-Robledo R, Jasso-Gutiérrez L, Muñoz-Hernández O. Live varicella vaccine in both immunocompromised and healthy children. Arch Medl Res 2002;31:85-7
22 Vazquez M, LaRussa PS, Gershon AA, Niccolai LM, Nuehlenbein CE, Steinberg SP, et al. Effectiveness over time of varicella vaccine. JAMA 2004;291:851-5   DOI   ScienceOn
23 Kim DJ, Park HS, Lee SY, Park KS, Kim TK, Song YH, et al. Epidemiology of varicella in Korea based on pediatrician's office practice. J Korean Pediatr Soc 1997;40:73-81
24 Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults : a case-control study. Lancet 2002;360:678-82   DOI   ScienceOn
25 Katsushima N, Yazaki N, Sakamoto M. Effect and followup study on varicella vaccine. Biken J 1984;27:51-8
26 Johnson CE, Stancin T, Fattlar D, Rome LP, Kumar ML. A long-term prospective study of varicella vaccine in healthy children. Pediatrics 1997;100:761-6   DOI   ScienceOn
27 LaRussa P, Steinberg S, Gershon AA. Varicella vaccine for immunocompromised children : results of collaborativestudies in the United States and Canada. J Infect Dis 1996;174: S320-3   DOI
28 Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, et al. Invasive Group A streptococcal infections in Ontario, Canada. N Engl J Med 1996;335:547-54   DOI   ScienceOn
29 Goldman GS. Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage. Vaccine 2003;21:4243-9   DOI   ScienceOn
30 Varis T, Vesikari T. Efficacy of high-titer live attenuated varicella vaccine in healthy young children. J Infect Dis 1996;174 Suppl 3:S330-4   DOI
31 Health Canada. Proceedings of the national varicella consensus conference. CCDR 1999;25:1-29
32 Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster : implications for mass vaccination against chickenpox. Vaccine 2002;20:2500-7   DOI   ScienceOn
33 Grose C. Varicella vaccination of children in the United States : Assessment after the first decade 1995-2005. J Clin Virol 2005;33:89-95   DOI   ScienceOn
34 Galil K, Lee B, Strine T, Carraher C, Baughman AL, Eaton M, et al. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med 2002;347:1909-15   DOI   ScienceOn
35 Arvin AM, Gershon AA. Live attenuated varicella vaccine. 1996 Annu Rev Microbiol 1996;50:59-100   DOI   ScienceOn